Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Differences between pharmacokinetics and toxicokinetics

P G Welling1

  • 1Parke-Davis Pharmaceutical Research Division, Warner-Lambert Company, Ann Arbor, Michigan 48106, USA.

Toxicologic Pathology
|March 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of food on drug absorption.

Annual review of nutrition·1996
Same author

The theophylline-enoxacin interaction: II. Changes in the disposition of theophylline and its metabolites during intermittent administration of enoxacin.

Clinical pharmacology and therapeutics·1989
Same author

The clinical pharmacokinetics of quinapril.

Angiology·1989
Same author

Evidence for isoxicam binding to site I as a primary site and to site II as a secondary site of human serum albumin.

Biochemical pharmacology·1989
Same author

Effects of food on drug absorption.

Pharmacology & therapeutics·1989
Same author

Effect of a high-fat meal on the bioavailability of a polymer-coated erythromycin particle tablet formulation.

Journal of clinical pharmacology·1989
Same journal

New Approach Methodologies (NAMs) for Carcinogenicity Evaluation.

Toxicologic pathology·2026
Same journal

2025 International Academy of Toxicologic Pathology (IATP) Satellite Symposium: Pathology Working Groups (PWGs) in Toxicologic Pathology.

Toxicologic pathology·2026
Same journal

Toxicologic Pathology Forum*: Opportunities and Challenges in the Use of Artificial Intelligence in Nonclinical Toxicologic Histopathology Evaluations.

Toxicologic pathology·2026
Same journal

New Modalities and Carcinogenicity Assessment.

Toxicologic pathology·2026
Same journal

Second Joint Annual Congress of the British Society of Toxicologic Pathology and the European Society of Toxicologic Pathology Special Issue.

Toxicologic pathology·2026
Same journal

Hemangiosarcomas in Intercostal Brown Adipose Tissues of the Sternum Induced by Urethane in TgrasH2 Mice.

Toxicologic pathology·2026
See all related articles

Toxicokinetics, an evolution of pharmacokinetics, now critically evaluates drug disposition at toxic doses. Understanding these drug disposition differences is crucial for predicting compound safety in humans.

Area of Science:

  • Pharmacology
  • Toxicology
  • Drug Metabolism

Background:

  • Pharmacokinetics (PK) compares drug disposition to observed effects.
  • Toxicokinetics (TK) is evolving similarly, moving beyond mere drug administration confirmation.
  • TK now critically evaluates drug disposition at toxic doses and links TK values to toxic events.

Purpose of the Study:

  • To highlight the evolution and distinct objectives of toxicokinetics compared to pharmacokinetics.
  • To emphasize the importance of toxicokinetics in assessing drug safety.
  • To discuss the challenges and critical need for TK in predicting human safety.

Main Methods:

  • Comparison of pharmacokinetic and toxicokinetic study designs and objectives.
  • Analysis of how different dose levels influence drug disposition factors (solubility, metabolism, etc.).

Related Experiment Videos

  • Evaluation of interspecies differences in disposition and organ sensitivity.

    • Main Results:

    • Toxicokinetic studies now provide critical evaluations of drug disposition at toxicologic doses.
    • Different dose levels in TK studies lead to significant changes in drug properties and necessitate distinct study designs.
    • TK and toxicodynamic data are essential for predicting human safety, despite interspecies variability.

    Conclusions:

    • Toxicokinetics has evolved into a critical discipline for evaluating drug safety at toxic doses.
    • Understanding dose-dependent dispositional changes is key to interpreting TK studies.
    • TK is indispensable for predicting the behavior and safety of compounds in humans.